Lyle Haskell, DPM
Podiatrist · Allen, TXNPI 1609825207
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,375 of the $26,102 with a category attached, or 66.6%. 32 manufacturers reported payments, led by Anika Therapeutics, Inc. at 49.8% of the total. Reporting peaked in 2019 at $9,818 and has fallen 90.7% since, to $908 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $191.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$13K
- Zimmer Biomet$8K
- Treace Medical Concepts, Inc.$1K
- Musculoskeletal Transplant Foundation Inc.$984
- Paratek Pharmaceuticals, Inc.$464
- Amgen$318
- plus $2K from 26 others
What the payments were for
- Consulting fees$17,37567%
- Travel & lodging$4,35517%
- Food & beverage$4,37217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 16 | $13,003 |
| Zimmer Biomet | 19 | $8,093 |
| Treace Medical Concepts, Inc. | 13 | $1,347 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $984 |
| Paratek Pharmaceuticals, Inc. | 10 | $464 |
| Amgen | 11 | $318 |
| Dexcom, Inc. | 6 | $298 |
| Novo Nordisk | 5 | $199 |
| Integra Lifesciences Corporation | 7 | $152 |
| Lilly USA, LLC | 4 | $145 |
| Smith+Nephew | 6 | $144 |
| Orthofix Medical, Inc. | 2 | $123 |
| AstraZeneca | 1 | $123 |
| Kerecis Limited | 3 | $91 |
| Stryker | 3 | $89 |
| Johnson & Johnson | 3 | $74 |
| AbbVie | 3 | $68 |
| Exact Sciences | 2 | $49 |
| Pylant Medical | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Nevro Corp. | 2 | $33 |
| Abbott | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Tactile Systems Technology Inc | 1 | $24 |
| Pfizer | 1 | $23 |
| Organogenesis Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTOSET$12,084
- AccuFill$5,130
- Nextremity Nextra Hammertoe$2,500
- Lapiplasty System$1,103
- HemiCAP$906
- NUZYRA$363
- KRYSTEXXA$244
- DEXCOM G7 GSS (161)$123
- DEXCOM STELO GLUCOSE BIOSENSOR$123
- AIRSUPRA$123
- Ozempic$122
- ZEPBOUND$122
- DEXCOM G6 TRANSMITTER$112
- Physio-Stim Osteogenesis Stimulator$110
How this compares
$26,102 in reported general payments places this provider in the 90th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 37 | $239 |
| Doxycycline Hyclate | 24 | $218 |
| Methylprednisolone | 12 | $99 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Allen
- Binoy ShethAllen$121K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.